Rod Middleton

1.7k total citations
54 papers, 701 citations indexed

About

Rod Middleton is a scholar working on Pathology and Forensic Medicine, Neurology and General Health Professions. According to data from OpenAlex, Rod Middleton has authored 54 papers receiving a total of 701 indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Pathology and Forensic Medicine, 6 papers in Neurology and 5 papers in General Health Professions. Recurrent topics in Rod Middleton's work include Multiple Sclerosis Research Studies (40 papers), Systemic Sclerosis and Related Diseases (7 papers) and Autoimmune and Inflammatory Disorders Research (5 papers). Rod Middleton is often cited by papers focused on Multiple Sclerosis Research Studies (40 papers), Systemic Sclerosis and Related Diseases (7 papers) and Autoimmune and Inflammatory Disorders Research (5 papers). Rod Middleton collaborates with scholars based in United Kingdom, United States and Germany. Rod Middleton's co-authors include David Ford, Kerina Jones, J. Gareth Noble, Hazel Lockhart-Jones, Lisa A. Osborne, Ann John, Philip A. Jones, Jeffrey Peng, Richard Nicholas and Ronan A Lyons and has published in prestigious journals such as Nature Communications, PLoS ONE and Neurology.

In The Last Decade

Rod Middleton

53 papers receiving 690 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rod Middleton United Kingdom 15 543 129 91 70 62 54 701
Tsegaye Tewelde Gebrehiwot Ethiopia 6 493 0.9× 96 0.7× 78 0.9× 50 0.7× 57 0.9× 8 838
Alessandro Finkelsztejn Brazil 14 402 0.7× 101 0.8× 74 0.8× 38 0.5× 53 0.9× 37 762
Andrius Kavaliūnas Sweden 15 415 0.8× 102 0.8× 43 0.5× 27 0.4× 46 0.7× 29 587
Sophie Kulaga Canada 8 441 0.8× 85 0.7× 88 1.0× 31 0.4× 59 1.0× 10 704
K.‐M. Myhr Norway 19 590 1.1× 141 1.1× 111 1.2× 36 0.5× 69 1.1× 26 839
Nina Grytten Norway 19 877 1.6× 185 1.4× 141 1.5× 40 0.6× 131 2.1× 36 1.1k
L. Morgante United States 10 417 0.8× 186 1.4× 153 1.7× 58 0.8× 68 1.1× 12 702
Sara Dishon Israel 12 466 0.9× 65 0.5× 99 1.1× 50 0.7× 65 1.0× 20 676
Laura Comber Ireland 14 386 0.7× 58 0.4× 285 3.1× 94 1.3× 25 0.4× 27 883
Kyla A. McKay Sweden 21 1.2k 2.2× 287 2.2× 214 2.4× 118 1.7× 146 2.4× 54 1.5k

Countries citing papers authored by Rod Middleton

Since Specialization
Citations

This map shows the geographic impact of Rod Middleton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rod Middleton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rod Middleton more than expected).

Fields of papers citing papers by Rod Middleton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rod Middleton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rod Middleton. The network helps show where Rod Middleton may publish in the future.

Co-authorship network of co-authors of Rod Middleton

This figure shows the co-authorship network connecting the top 25 collaborators of Rod Middleton. A scholar is included among the top collaborators of Rod Middleton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rod Middleton. Rod Middleton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Moura, Alexandra, Valentina Giunchiglia, William Trender, et al.. (2025). Large-scale online assessment uncovers a distinct Multiple Sclerosis subtype with selective cognitive impairment. Nature Communications. 16(1). 6938–6938. 1 indexed citations
3.
Rad, Esmaeil Yousefi, Somayeh Saboori, Thanasis G. Tektonidis, et al.. (2024). A systematic review and meta-analysis of Dietary Inflammatory Index and the likelihood of multiple sclerosis/ demyelinating autoimmune disease. Clinical Nutrition ESPEN. 62. 108–114. 3 indexed citations
4.
Stahmann, Alexander, David Ellenberger, Niklas Frahm, et al.. (2024). Disease-modifying therapy initiation patterns in multiple sclerosis in three large MS populations. Therapeutic Advances in Neurological Disorders. 17. 4233514132–4233514132. 3 indexed citations
5.
Kamudoni, Paul, Jeffrey Johns, Karon F. Cook, et al.. (2024). Measuring fatigue in people with multiple sclerosis – which questionnaire should be used? A Plain Language Summary of Publication. Neurodegenerative Disease Management. 14(1). 5–9. 1 indexed citations
6.
Wiles, Kate, Azza Ismail, Surabhi Nanda, et al.. (2023). Developing evidence-based guidelines for the safety of symptomatic drugs in multiple sclerosis during pregnancy and breastfeeding: A systematic review and Delphi consensus. Multiple Sclerosis Journal. 29(3). 395–406. 1 indexed citations
7.
Middleton, Rod, I Farkas, David R. Owen, et al.. (2023). Comparing the Pathology, Clinical, and Demographic Characteristics of Younger and Older‐Onset Multiple Sclerosis. Annals of Neurology. 95(3). 471–486. 13 indexed citations
8.
Ellenberger, David, Tina Parciak, Waldemar Brola, et al.. (2022). Comparison of employment among people with Multiple Sclerosis across Europe. Multiple Sclerosis Journal - Experimental Translational and Clinical. 8(2). 3090453853–3090453853. 6 indexed citations
9.
Frahm, Niklas, David Ellenberger, Judith Haas, et al.. (2022). SARS-CoV-2 vaccination in patients with multiple sclerosis in Germany and the United Kingdom: Gender-specific results from a longitudinal observational study. The Lancet Regional Health - Europe. 22. 100502–100502. 17 indexed citations
10.
Garjani, Afagh, Rachael Hunter, Graham Law, et al.. (2021). Mental health of people with multiple sclerosis during the COVID-19 outbreak: A prospective cohort and cross-sectional case–control study of the UK MS Register. Multiple Sclerosis Journal. 28(7). 1060–1071. 20 indexed citations
11.
Garjani, Afagh, Rod Middleton, Rachael Hunter, et al.. (2021). COVID-19 is associated with new symptoms of multiple sclerosis that are prevented by disease modifying therapies. Multiple Sclerosis and Related Disorders. 52. 102939–102939. 36 indexed citations
12.
Nair, Roshan das, Rachael Hunter, Afagh Garjani, et al.. (2021). Challenges of developing, conducting, analysing and reporting a COVID-19 study as the COVID-19 pandemic unfolds: an online co-autoethnographic study. BMJ Open. 11(6). e048788–e048788. 4 indexed citations
13.
Kamudoni, Paul, Jeffrey Johns, Karon F. Cook, et al.. (2021). Standardizing fatigue measurement in multiple sclerosis: the validity, responsiveness and score interpretation of the PROMIS SF v1.0 – Fatigue (MS) 8a. Multiple Sclerosis and Related Disorders. 54. 103117–103117. 16 indexed citations
14.
Middleton, Rod, Owen Pearson, Gillian Ingram, et al.. (2020). A Rapid Electronic Cognitive Assessment Measure for Multiple Sclerosis: Validation of Cognitive Reaction, an Electronic Version of the Symbol Digit Modalities Test. Journal of Medical Internet Research. 22(9). e18234–e18234. 13 indexed citations
15.
Garjani, Alireza, Nikos Evangelou, Rajiv Nair, et al.. (2020). COVID-19 in people with MS: a large community-based study of the UK MS register. Multiple Sclerosis Journal. 26. 46–47. 1 indexed citations
16.
Vickaryous, Nicola, Mark Jitlal, Benjamin M. Jacobs, et al.. (2020). Remote testing of vitamin D levels across the UK MS population—A case control study. PLoS ONE. 15(12). e0241459–e0241459. 5 indexed citations
17.
Vickaryous, Nicola, Alireza Garjani, Mark Jitlal, et al.. (2020). Vitamin D levels in the UK MS population and COVID-19 susceptibility. Multiple Sclerosis Journal. 26. 55–55. 1 indexed citations
18.
Salter, Amber, Alexander Stahmann, David Ellenberger, et al.. (2020). Data harmonization for collaborative research among MS registries: A case study in employment. Multiple Sclerosis Journal. 27(2). 281–289. 17 indexed citations
19.
Middleton, Rod, Arron Lacey, Owen Pearson, et al.. (2019). 030 Automating clinical audit in neurology. Journal of Neurology Neurosurgery & Psychiatry. 90(12). A18.1–A18. 1 indexed citations
20.
Middleton, Rod, Jeff Rodgers, Gavin Giovannoni, et al.. (2017). A Comparison of participant supplied EDSS scores and clinically submitted data via the UK MS Register. Cronfa (Swansea University). 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026